Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli.Procalcitonin Antibody refers to the specific protein which can qualitatively and quantitatively detect the PCT level. PCT level is a parameter for the diagnosis and monitoring of bacterial inflammatory diseases
This report contains market size and forecasts of Procalcitonin Antibody in global, including the following market information:
Global Procalcitonin Antibody Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Procalcitonin Antibody Market Sales, 2017-2022, 2023-2028, (mg)
Global top five Procalcitonin Antibody companies in 2021 (%)
The global Procalcitonin Antibody market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Polyclonal Procalcitonin Antibody Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Procalcitonin Antibody include Thermo Fisher, Roche Diagnostics, bioMerieux, HyTest, Wondfo, Ningbo Medicalsystem Biotechnology, Snibe, Vazyme Biotech and Getein Biotech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Procalcitonin Antibody manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Procalcitonin Antibody Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (mg)
Global Procalcitonin Antibody Market Segment Percentages, by Type, 2021 (%)
Polyclonal Procalcitonin Antibody
Monoclonal Procalcitonin Antibody
Global Procalcitonin Antibody Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (mg)
Global Procalcitonin Antibody Market Segment Percentages, by Application, 2021 (%)
Hospital
Medical research institutions
Others
Global Procalcitonin Antibody Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (mg)
Global Procalcitonin Antibody Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Procalcitonin Antibody revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Procalcitonin Antibody revenues share in global market, 2021 (%)
Key companies Procalcitonin Antibody sales in global market, 2017-2022 (Estimated), (mg)
Key companies Procalcitonin Antibody sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher
Roche Diagnostics
bioMerieux
HyTest
Wondfo
Ningbo Medicalsystem Biotechnology
Snibe
Vazyme Biotech
Getein Biotech
Hotgen Biotech
Lumigenex
Shanghai Medicine'nest Pharmaceutical
Kitgen
Beijing KeyGen
Fantibody